Skip to content
Loading company
Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues10,84213,09415,45117,77221,45425,37127,51829,77131,79733,172
Provision for credit losses1,0881,0111,274–––––––
Realized investment gains (losses)–0872081,91446(304)(26)(44)162
Research and development8349531,071–––––––
Selling, general and administrative2,1172,4002,8553,1123,9314,5594,3563,8684,1484,262
Total operating expenses9,25610,96713,25715,05318,16521,10923,68124,74326,47227,107
Operating income1,5862,1272,1942,7193,2894,2623,8375,0285,3256,065
Interest expense3777115209232304347382441
Other non-operating income (expense)45731822791,776(163)(471)3834227
Income before taxes1,6312,2002,3762,9985,0654,0993,3665,4115,3296,292
Income tax expense230405319539863(70)9471,1651,1821,059
Net income from continuing operations1,4011,7952,0572,4594,2024,1692,4194,2464,1475,233
Net income1,4011,7952,0572,4594,2024,1692,4194,2464,1475,233
Net income to common shareholders–––2,4594,2024,1692,4194,2464,1475,233
PYPL · FinancialMD